Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality. The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.
Stemtech Corporation Appoints Alejandro Carrillio President, Latin Markets
Stemtech Corporation promoted Alejandro Carrillo to President of Latin Markets, elevating him from his previous role as Vice President of Global Sales.
Carrillo originally joined the company in 2015 as General Manager of Stemtech Mexico, where he built the unit into the company's largest and most productive market segment.
The appointment places the executive responsible for the company's strongest growth engine in direct oversight of strategy and distributor development across Latin America.